Desai P, Patlolla RR, Singh M
Molecular Membrane Biology, 01 Oct 2010, 27(7):247-259
PMID: 21028936 PMCID: PMC3061229
Topical or transdermal drug delivery is challenging because the skin acts as a natural and protective barrier. Therefore, several methods have been examined to increase the permeation of therapeutic molecules into and through the skin. One approach is to use the nanoparticulate delivery system. Starting with liposomes and other vesicular systems, several other types of nanosized drug carriers have been developed such as solid lipid nanoparticles, nanostructured lipid carriers, polymer-based nanoparticles and magnetic nanoparticles for dermatological applications. This review article discusses how different particulate systems can interact and penetrate into the skin barrier. In this review, the effectiveness of nanoparticles, as well as possible mode of actions of nanoparticles, is presented. In addition to nanoparticles, cell-penetrating peptide (CPP)-mediated drug delivery into the skin and the possible mechanism of CPP-derived delivery into the skin is discussed. Lastly, the effectiveness and possible mechanism of CPP-modified nanocarriers into the skin are addressed.
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Cell-penetrating peptides as a novel transdermal drug delivery system.
Nasrollahi SA, Taghibiglou C, Azizi E, Farboud ES
Chem Biol Drug Des, 80(5):639-646, 31 Aug 2012
Cited by: 90 articles | PMID: 22846609
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S, Patel N, Shah MK, Khatri P, Vora N
J Pharm Sci, 106(2):423-445, 16 Nov 2016
Cited by: 130 articles | PMID: 27865609
Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M, Diab R, Elaissari A, Fessi H
Int J Pharm, 535(1-2):1-17, 27 Oct 2017
Cited by: 217 articles | PMID: 29111097
Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K
Int J Nanomedicine, 14:6135-6150, 02 Aug 2019
Cited by: 32 articles | PMID: 31447556 | PMCID: PMC6683961
Funders who supported this work.
